Metraipolis › archive › dc_cd1542725edd

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023) — Europe PMC PMID:42079413

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42079413
DOI: 10.1016/j.esmorw.2026.100700
License (as archived): solo-consultazione
Archived: 2026-11-03T06:23:26.185Z
SHA-256 of the archived text: 216969a1f723810e4d2a19d41fa6d8d4ac0a1c7b5fd084f04ac7ccb23e1dec6f
Stable URL of this page: https://metraipolis.com/documento/dc_cd1542725edd

How to cite

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023) — Europe PMC PMID:42079413 — Europe PMC (en), https://europepmc.org/article/MED/42079413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd1542725edd (Metraipolis archive dc_cd1542725edd, sha256 216969a1f723810e4d2a19d41fa6d8d4ac0a1c7b5fd084f04ac7ccb23e1dec6f)

BibTeX

@misc{dccd1542725edd,
  title = {Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023) — Europe PMC PMID:42079413},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42079413},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd1542725edd; sha256 216969a1f723810e4d2a19d41fa6d8d4ac0a1c7b5fd084f04ac7ccb23e1dec6f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42079413. Agents can read the archived copy with the MCP tool read_document.